View |
|
DRP-6639-01
|
Omeprazole
|
KOMPRAZ
|
20 mg
|
Delayed-release Capsule
|
Proton Pump Inhibitor
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
08 July 2022
|
12 April 2026
|
View |
|
DRP-6912-03
|
Ciprofloxacin (as hydrochloride)
|
Unbranded
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Fluroquinolone)
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
08 July 2022
|
07 July 2025
|
View |
|
DRP-8312-03
|
Paracetamol + Phenylpropanolamine HCl + Chlorphenamine maleate
|
Flu-Away
|
325mg/ 20mg/ 2mg
|
Tablet
|
Analgesic/ Antipyretic/ Decongestant (Sympathomimetic)/ Antihistamine
|
Philmed Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
08 July 2022
|
03 September 2025
|
View |
|
DRP-8475
|
Paracetamol + Ibuprofen
|
Bupasaph-TF
|
325 mg/200 mg
|
Tablet
|
Analgesic/ Antipyretic/ Non-Steroidal Anti Inflammatory Drug
|
SAPPHIRE LIFESCIENCES PVT. LTD
|
INDIA
|
Renewal
|
08 July 2022
|
12 July 2027
|
View |
|
DRP-8511
|
Tramadol Hydrochloride
|
Tramal
|
50 mg
|
Dispersible Tablet
|
Opioid Analgesic
|
Farmaceutici Foramen S.P.A.
|
Italy
|
Automatic Renewal
|
08 July 2022
|
23 July 2027
|
View |
|
DRP-8586-03
|
Trimetazidine dihydrochloride
|
Diazitri
|
35 mg
|
Modified-Release Tablet
|
Anti-Angina
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
21 March 2024
|
18 December 2029
|
View |
|
DRP-8641-03
|
Hyoscine N-Butylbromide + Paracetamol
|
HYOSIN PLUS
|
10mg/500mg
|
Film-Coated Tablet
|
Anticholinergic/Analgesic/Antipyretic
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
08 July 2022
|
23 January 2025
|
View |
|
DRP-8843-01
|
Ascorbic Acid
|
Enhanzee
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate)
|
Capsule
|
Vitamin
|
LifeSquare Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
08 July 2022
|
11 May 2025
|
View |
|
DRP-9163-01
|
Celecoxib
|
Recosan
|
200mg
|
Capsule
|
Selective COX-2 Inhibitor
|
Zim Laboratories Limited
|
India
|
Renewal
|
08 July 2022
|
21 September 2028
|
View |
|
DRP-10475-04
|
Telmisartan
|
Teldra
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
08 July 2022
|
30 September 2026
|
View |
|
DRP-10613-01
|
Febuxostat
|
Febufast 80
|
80 mg
|
Film-Coated Tablet
|
Antigout
|
Acme Formulation Pvt. Ltd.
|
India
|
CLIDP Conversion
|
08 July 2022
|
16 November 2026
|
View |
|
DRP-10868-04
|
ASCORBIC ACID + ZINC
|
CHARMCEE PLUS ZINC
|
533.40mg ( equivalent to 600mg Sodium Ascorbate)+ 10mg ( equivalent to 27.45mg Zinc Sulfate)
|
Capsule
|
VITAMIN/MINERAL
|
EURASIA RESEARCH PHARMA CORPORATION
|
Philippines
|
CLIDP Conversion
|
08 July 2022
|
30 October 2025
|
View |
|
DRP-11705-01
|
Mefenamic Acid
|
Fencare
|
50 mg/5 mL
|
Suspension
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
08 July 2022
|
16 June 2025
|
View |
|
DRP-6974-02
|
Salmeterol (as Xinafoate) + Fluticasone Propionate
|
Salmed
|
50 mcg/250 mcg
|
Dry Powder for Inhalation in Capsule
|
Anti-Asthma ( Adrenergic-Corticosteroid Combination)
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
21 July 2022
|
25 August 2025
|
View |
|
DRP-10375-01
|
CLINDAMYCIN (as Phosphate)
|
AMSOCYN-300
|
150 mg/mL (300 mg/2 mL)
|
Solution for Injection (I.M./I.V.)
|
Antibacterial (Lincosamide)
|
North China Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
21 July 2022
|
16 September 2026
|
View |
|
DRP-4099-01
|
Fentanyl
|
Fentalex
|
12.5 mcg
|
Hour Transdermal Patch
|
Opioid Analgesic
|
HEXAL AG
|
Germany
|
Renewal
|
17 October 2022
|
14 November 2027
|
View |
|
DRP-7309
|
Tramadol Hydrochloride + Paracetamol
|
Trap
|
37.5 mg/325 mg
|
Film-Coated Tablet
|
Opioid in combination with non-opioid analgesic
|
Cadila Healthcare Limited
|
India
|
Renewal
|
05 August 2022
|
20 November 2027
|
View |
|
DRP-11402-01
|
Folic Acid
|
FoliCass
|
5 mg
|
Tablet
|
Antianemic
|
Acme Formulation Pvt. Ltd
|
India
|
CLIDP Conversion
|
05 August 2022
|
09 March 2027
|
View |
|
DRP-11691-01
|
Montelukast (as sodium) + Levocetirizine hydrochloride
|
Allerkast
|
10 mg/5 mg
|
Film-Coated Tablet
|
Leukotriene Receptor Antagonist/ Antihistamine
|
Akums Drugs & Pharmaceuticals Ltd. (Plant I - Solid Oral Dosage Facility)
|
India
|
CLIDP Conversion
|
05 August 2022
|
18 April 2027
|
View |
|
DRP-4895-04
|
Etoricoxib
|
Coxicare
|
90 mg
|
Film-Coated Tablet
|
Selective COX-2 Inhibitor
|
Scott-Edil Pharmacia Ltd.
|
India
|
Renewal
|
22 November 2023
|
07 November 2028
|